Skip to main content

Table 2 Treatments provided during the 72 h following enrolment and outcomes of the study cohort

From: Haemoglobin concentration and volume of intravenous fluids in septic shock in the ARISE trial

Treatments and outcomes Cohort (N = 1275)
Treatments  
Central venous cannula inserted – N (%) 1053 (82.6%)
Arterial cannula inserted – N (%) 1082 (84.9%)
Admitted to ICU – N (%) 1092 (85.6%)
Received surgery – N (%) 117 (9.2%)
Received mechanical ventilationaN (%) 480 (37.6%)
Received an infusion of a vasoactive agentbN (%) 858 (67.3%)
Duration of vasoactive agent infusion – hours (IQR) 29 (12–57)
Outcomes
 Invasive ventilation
  Number that received invasive ventilationcN (%) 352 (27.6%)
  Duration of invasive ventilation – hours (IQR) 61 (22–163)
 Length of stay – days (IQR)
  ICU 2.6 (1.3–5.0)
  Hospital 8.1 (4.9–15.3)
 Mortality – N (%)
  ICU 109 (8.5%)
  Hospital 162 (12.7%)
  Day 28 163 (12.8%)
  Day 90 193 (15.1%)
  1. aMechanical ventilation included invasive and non-invasive modes
  2. bInfusion of vasoactive drugs included noradrenaline, adrenaline, metaraminol, phenylephrine and/or dopamine for at least 30 min
  3. cInvasive mechanical ventilation at any time during hospital admission